Sarepta Therapeutics (NASDAQ:SRPT) Price Target Lowered to $161.00 at Royal Bank of Canada
Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its price target reduced by Royal Bank of Canada from $165.00 to $161.00 in a research note issued to investors on Thursday,Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. SRPT has been the subject of a number of other reports. Piper Sandler decreased […]
Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its price target reduced by Royal Bank of Canada from $165.00 to $161.00 in a research note issued to investors on Thursday,Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. SRPT has been the subject of a number of other reports. Piper Sandler decreased […]
